ICV Global

What ICV Global does

ICV Global is a privately-held specialty chemicals enterprise headquartered in Hamburg, Germany, focused on the development, co-production, and distribution of branded chemical products across multiple industrial segments. The company's portfolio centers on eight core product lines: Metoxsil (its flagship pyrogenic fumed silica available in hydrophilic and hydrophobic grades), pharmaceutical and food-grade lactose, povidone polymers across multiple K-values and copolymers, Puralk (sodium and potassium hydroxide pellets), Neumag (magnesium aluminium silicate), N-Methyl Pyrrolidone, 2-Pyrrolidone, and methylene chloride. These products serve six vertical segments: pharmaceutical and cosmeceutical manufacturing, food and beverage, personal care and cosmetics, paints and coatings, adhesives and sealants, and material sciences including electronics and lithium-ion battery fabrication.

The company operates an asset-light, co-production and distribution model rather than primary manufacturing. Its commercial footprint spans three regional offices — Hamburg (Europe), RAK in the UAE (Middle East-Africa), and Shanghai via the wholly-owned entity Shanghai ICV Chemical Technology Co. Ltd (Far East) — reaching an estimated 357+ customers across 70 targeted countries with 67 product variants. ICV positions its innovation centers at co-production facilities as the locus of formulation and product development, while commercial activity is executed through regional sales offices rather than digital channels. Pricing is not publicly disclosed, no API or e-commerce offering exists, and revenue mechanics follow a traditional B2B specialty chemicals distribution model with no segment-level disclosure.

Founded circa 1999 (based on the company's own '25 years' claim), ICV Global is privately held with no disclosed external investors, parent company, M&A activity, or funding rounds. Its go-to-market relies on direct enterprise sales supported by downloadable corporate and product collateral and a mailing-list newsletter; no social media presence or named customer logos are evident. The current strategic posture emphasizes sustainability, International Pharmacopeia compliance for pharmaceutical inputs, and stated revenue ambitions of $100M against the modest six-employee core team, suggesting the company operates more as a brand-and-distribution platform anchored on partner co-production capacity than as a vertically integrated chemicals manufacturer.

Name

ICV Global

Legal name

ICV Global

Website

https://icvglobal.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

1–10 employees

Short description

ICV Global is a Hamburg-headquartered specialty chemicals distributor and co-producer marketing branded excipients, polymers, and solvents (Metoxsil, Povidones, Puralk, Neumag, NMP) to pharmaceutical, food, personal care, paints, and industrial customers across 70 countries.

Ownership category

akta.pro rank

Product category

Specialty Chemicals

NAICS

Chemical Manufacturing (325), Custom Compounding of Purchased Resins (325991)

SIC

Miscellaneous Chemical Products (2890), Chemicals & Allied Products (2800), Industrial Organic Chemicals (2860)

akta.pro primary industry

Silica (Quartz, Fumed, Precipitated) (IMAEAFAD)

akta.pro secondary industries

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Medical & Food-Contact Specialty Compounds (IMANABAK), Industrial & Protective Coatings (IMAEAGAB)

Keywords

• Specialty chemicals
• Pharmaceutical excipients
• Fumed silica
• Chemical distribution
• Industrial additives

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Distribution channels1 record

Marketing channels2 records

Core offering

ICV Global develops, co-produces, and supplies specialty chemical products for pharmaceutical, cosmeceutical, food and beverage, personal care, paints and coatings, adhesives and sealants, and material science manufacturers. Its flagship offering is Metoxsil pyrogenic fumed silica, supported by a portfolio of pharmaceutical-grade lactose, povidone polymers, alkali hydroxides under the Puralk brand, magnesium aluminium silicate (Neumag), N-Methyl Pyrrolidone, 2-Pyrrolidone, and Methylene Chloride. The company operates innovation centers at its co-production facilities to support formulation and quality compliance with international pharmacopeia standards.

Product overview

ICV Global is a chemical products company offering a portfolio of specialty chemicals across multiple product lines: Metoxsil (pyrogenic fumed silica), Lactose (pharmaceutical and food grades), Povidones (polymers including PVPs and copolymers), Puralk (sodium/potassium hydroxide pellets), Neumag (magnesium aluminium silicate), N-Methyl Pyrrolidone, 2-Pyrrolidone, and Methylene Chloride. These products serve diverse industries including Pharmaceuticals & Cosmeceuticals, Food & Beverages, Personal Care & Cosmetics, Paints & Coatings, Adhesives & Sealants, and Material Sciences. The company operates innovation centers at co-production facilities continuously developing progressive solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Metoxsil: ICV's flagship product - Pyrogenic Fumed Silica (Colloidal Silicon Dioxide) used in pharmaceutical preparations, food products, paints, adhesives, and more.
• Puralk
• Neumag
• OraRez W
• N-Vinylpyrrolidone/N-Vinylimidazole copolymer (VP/VI)

Products and services

• Metoxsil (Pyrogenic Fumed Silica)

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• IMCD: Specialty chemicals and ingredients distributor with deep pharma and personal-care coverage; competes with ICV's distribution model for excipients, fumed silica, and solvents across Europe and emerging markets.
• Azelis: Specialty chemicals and ingredients distributor with strong pharma, personal care, and coatings portfolios; closest peer to ICV's regional-distributor-plus-co-production model, particularly in EMEA and APAC.
• Evonik Industries: Produces AEROSIL, the global benchmark for pyrogenic fumed silica and the principal head-to-head competitor to ICV's Metoxsil across pharma, coatings, and adhesives end-uses.
• Cabot Corporation: Manufactures Cab-O-Sil fumed silica and specialty carbons, competing directly with Metoxsil in rheology modification, anti-caking, and reinforcement applications.
• Ashland: Global supplier of pharmaceutical excipients including povidones, coatings polymers, and specialty additives — a direct overlap with ICV's Povidone and OraRez W product lines for oral and mucoadhesive formulations.
• Wacker Chemie: Manufactures HDK fumed silica, which directly competes with ICV's Metoxsil franchise. Also produces specialty polymers and pharmaceutical-grade excipients, overlapping ICV's povidone and silicone-rubber-adjacent lines.
• DF Pharma (DFE Pharma): Specialty supplier of pharmaceutical excipients including lactose, mannitol, and inhalation-grade carriers — direct overlap with ICV's pharmaceutical lactose range across direct-compression and pulmonary delivery grades.

Broad incumbents

• Brenntag: World's largest chemical distribution company, supplying solvents, excipients, and specialty additives across pharma, food, and industrial markets — same end-markets as ICV but at vastly greater scale.
• Merck KGaA (Life Science / MilliporeSigma): Produces pharmaceutical excipients, solvents (including NMP alternatives), and silica-based products under the Life Science and Performance Materials divisions — overlapping ICV's pharma excipient and NMP lines.
• BASF: Global chemical major with pharmaceutical excipients, solvents (NMP, 2-Pyrrolidone), and silica-related portfolios. Broad incumbent rather than direct niche competitor to ICV's specialty range.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/icvglobal

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ICV Global